Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study

NCT06344650 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06344650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06344650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2023
Completion date
April 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly